Mark E. Hayes
16Patents
6h-index
12Co-inventors
63Inventor score
Filing activity: May 15, 2003 → May 25, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8496961B2 | Delivery of nucleic acid-like compounds | Human Necessities | 20 | Active |
| US10456360B2 | Stabilizing camptothecin pharmaceutical compositions | Emerging Cross-Sectional Technologies | 11 | Active |
| US8883200B2 | Delivery of nucleic acid-like compounds | Human Necessities | 8 | Active |
| US10993914B2 | Stabilizing camptothecin pharmaceutical compositions | Emerging Cross-Sectional Technologies | 7 | Active |
| US9737485B2 | Remote loading of sparingly water-soluble drugs into liposomes | Human Necessities | 6 | Active |
| US10087464B2 | Compositions and methods for delivering nucleic acid to a cell | Chemistry; Metallurgy | 6 | Active |
| US11591544B2 | Ionizable cationic lipids | Emerging Cross-Sectional Technologies | 4 | Active |
| US10507182B2 | Remote loading of sparingly water-soluble drugs into liposomes | Human Necessities | 1 | Active |
| US12077725B2 | Ionizable cationic lipids | Emerging Cross-Sectional Technologies | 1 | Active |
| US12064479B2 | Lipid nanoparticles for delivery of nucleic acids and methods of use thereof | Chemistry; Metallurgy | 1 | Active |
| US10004759B2 | Remote loading of sparingly water-soluble drugs into lipid vesicles | Human Necessities | 1 | Active |
| US12059497B2 | Stabilizing camptothecin pharmaceutical compositions | Emerging Cross-Sectional Technologies | 1 | Active |
| US12070471B2 | Remote loading of sparingly water-soluble drugs into lipid vesicles | Human Necessities | 0 | Active |
| US10722467B2 | Remote loading of sparingly water-soluble drugs into liposomes | Human Necessities | 0 | Active |
| US12331264B2 | Lipid nanoparticles for delivery of nucleic acids and methods of use thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US11583544B2 | Remote loading of sparingly water-soluble drugs into lipid vesicles | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.